We are delighted to welcome you to the European Association for the Study of the Liver (EASL) and the Turkish Association for the Study of the Liver (TASL) Digital Hepatology Meeting “Clinical Innovations and Controversies in ILC 2021” on October 16, 2021. EASL and TASL have been collaborated to organize educational activities for a long time. We have brought together a series of excellent lectures delivered by a renowned national and international faculty. The program promises high-class educational opportunities for all who are interested in clinical practice and research in hepatology.

The program of this educational activity consist of 4 sessions spanning a whole day. They include Metabolic Liver Diseases, Viral Hepatitis, HCC, and Cirrhosis and Liver Transplantation. To bring out the clinical relevance of the material covered, each session will incorporate case-based discussion by a panel of faculty experts with interactive participation of the audience.

Target audience is gastroenterologist, hepatologists, trainees, infectious disease specialists, emergency physicians, primary care physicians with interest in hepatology, translational and clinical researchers and other health care professionals.

Highlights:

• One-day of presentations of the current information on the mechanism and management of chronic conditions in hepatology.
• Case-base discussion
• Interactive program promoting networking with renowned scientists and leading experts.

The program is organized and delivered by the EASL and TASL, lead by Drs Thomas Berg and Ramazan Idilman. The TASL and EASL wish you an enjoyable meeting. They are enthusiastic that you will find the program stimulating and informative.

More information about the event: https://globaliq.live/broadcast/TKAD-best-of-easl-ilc-at-tasl—clinical-innovations-and-controversies-26

More information about the organiser: https://www.tkad.org.tr/